Kenta Biotech
Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections.
Kenta Biotech is a company in biotechnology, medical based in Europe, Middle East, and Africa (EMEA), founded in 2006.
Kenta Biotech is positioned in biotechnology, medical, a segment that rewards a clear, focused offering.
Its base of operations is Europe, Middle East, and Africa (EMEA).
Directory data places it at the Series_B stage.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $12M in funding.
| Sector | Biotechnology, Medical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2006 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $12,000,000 |
Website: www.kentabiotech.com
Browse related
Sign in to view the contact information we hold for Kenta Biotech.
Create a free account
Create a free account